Raising Capital and Planning an IPO in Healthcare and Life Sciences

Raising Capital and Planning an IPO in Healthcare and Life Sciences

May 31, 2016
7:30 AM – 9:15 AM
McMillan LLP, Brookfield Place, Suite 4400 – 181 Bay Street, Toronto, ON

For organizations considering, preparing for, or undergoing a major transaction – be it an IPO, sale or a milestone event – building a strategy to stay ahead can be a challenge. Please join us as our panel explores the following:

• What is currently happening in the Canadian & US economies & capital markets
• What options are available for raising private vs. public equity or debt
• How to develop a strategic plan for an exit transaction whether it be an IPO, sale or another event and what are the advantages and disadvantages of each option
• What should you think about in getting the company ready for the event from a legal, regulatory, internal controls, and corporate governance standpoint
• Typical next steps, opportunities and challenges after the transaction is complete
• Lessons learned from previous transactions

Co-modeators:

• Paul Davis, Co-Chair Capital Markets and M&A, McMillan
• Diana Dunlop, Senior Manager, Transaction Advisory, Deloitte

Panelists:

• Bruce Chapple, Co-Chair Private Equity, McMillan
• Pascal Tremblay, President and Managing Partner, Novacap
• Ungad Chadda, Senior vice President, TSX
• David Dalziel, Partner, Deloitte

For more information contact Nancy Tencer via phone 416.865.7937 or email [email protected].